Zanaflex
NDC 21695-373
Product Information
Zanaflex is a NDA-approved product labeled by Rebel Distributors Corp. This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It is supplied as a white product. This product entry covers the primary NDC 21695-373 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
BLUE (C48333 - STANDARD BLUE OPAQUE)
4;MG
Code Structure Chart
Product Details
What is NDC 21695-373?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TIZANIDINE HYDROCHLORIDE (UNII: B53E3NMY5C)
- TIZANIDINE (UNII: 6AI06C00GW) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- HYDROXYPROPYL CELLULOSE (UNII: RFW2ET671P)
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- SUCROSE (UNII: C151H8M554)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- GELATIN (UNII: 2G86QN327L)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 485485 - tiZANidine HCl 4 MG Oral Capsule
- RxCUI: 485485 - tizanidine 4 MG Oral Capsule
- RxCUI: 485485 - tizanidine 4 MG (as tizanidine HCl 4.576 MG) Oral Capsule
- RxCUI: 583211 - Zanaflex 4 MG Oral Capsule
- RxCUI: 583211 - tizanidine 4 MG Oral Capsule [Zanaflex]
* Please review the full disclaimer at the bottom of this page.